Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System
Status: | Recruiting |
---|---|
Conditions: | Chronic Pain, Post-Surgical Pain, Orthopedic, Orthopedic |
Therapuetic Areas: | Musculoskeletal, Orthopedics / Podiatry |
Healthy: | No |
Age Range: | 21 - 90 |
Updated: | 4/6/2019 |
Start Date: | September 5, 2017 |
End Date: | December 2019 |
A Prospective, Comparative Effectiveness Randomized Controlled Trial of SPR Peripheral Nerve Stimulation (PNS) Therapy for the Treatment of Pain Following Total Knee Arthroplasty (TKA) Utilizing Preoperative Lead Placement
The purpose of this study is to determine if electrical stimulation (small levels of
electricity) in addition to the standard of care can safely and effectively reduce pain
following total knee replacement more than the standard of care, alone. This study involves a
device called the SPRINT Beta System. The SPRINT Beta System delivers mild electrical
stimulation to nerves in the leg that received the knee replacement. The SPRINT Beta System
includes a small wire (called a "lead") that is placed through the skin in the upper leg. It
also includes a device worn on the body that delivers stimulation (called the SPRINT Beta
Stimulator). About half the subjects in this study will receive the SPRINT Beta system
(treatment group) and half will not (control group). Both groups will receive the standard of
care.
electricity) in addition to the standard of care can safely and effectively reduce pain
following total knee replacement more than the standard of care, alone. This study involves a
device called the SPRINT Beta System. The SPRINT Beta System delivers mild electrical
stimulation to nerves in the leg that received the knee replacement. The SPRINT Beta System
includes a small wire (called a "lead") that is placed through the skin in the upper leg. It
also includes a device worn on the body that delivers stimulation (called the SPRINT Beta
Stimulator). About half the subjects in this study will receive the SPRINT Beta system
(treatment group) and half will not (control group). Both groups will receive the standard of
care.
Key Inclusion Criteria:
- Scheduled to undergo a primary unilateral total knee replacement procedure
Key Exclusion Criteria:
- Body Mass Index > 40 kg/m2
- Conditions that place the subject at increased risk of infection
- History of valvular heart disease
- Implanted electronic device
- Bleeding disorder
- Allergy to skin surface electrodes and/or medical-grade adhesive tapes
- Pregnant
We found this trial at
5
sites
New Albany, Ohio 43054
Principal Investigator: Keith Berend, MD
Phone: 614-221-6331
Click here to add this to my saved trials
9500 Euclid Avenue
Cleveland, Ohio 44106
Cleveland, Ohio 44106
216.444.2200
Principal Investigator: Hesham Elsharkawy, MD
Phone: 216-636-1146
Cleveland Clinic Cleveland Clinic is committed to principles as presented in the United Nations Global...
Click here to add this to my saved trials
2301 Erwin Rd
Durham, North Carolina 27710
Durham, North Carolina 27710
919-684-8111
Principal Investigator: Stuart Grant, MB, ChB
Phone: 919-681-1804
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
Click here to add this to my saved trials
Click here to add this to my saved trials
9500 Gilman Dr
La Jolla, California 92093
La Jolla, California 92093
(858) 534-2230
Principal Investigator: Brian Ilfeld, MD, MS
Phone: 858-822-1288
The University of California, San Diego UC San Diego is an academic powerhouse and economic...
Click here to add this to my saved trials